Published in Neuroscientist on April 01, 2001
BK potassium channel modulation by leucine-rich repeat-containing proteins. Proc Natl Acad Sci U S A (2012) 1.71
Calcium-activated potassium channels and endothelial dysfunction: therapeutic options? Br J Pharmacol (2009) 1.60
The RCK2 domain of the human BKCa channel is a calcium sensor. Proc Natl Acad Sci U S A (2007) 1.38
Profiling the phospho-status of the BKCa channel alpha subunit in rat brain reveals unexpected patterns and complexity. Mol Cell Proteomics (2008) 1.29
Identification of a BK channel auxiliary protein controlling molecular and behavioral tolerance to alcohol. Proc Natl Acad Sci U S A (2008) 1.24
slo K(+) channel gene regulation mediates rapid drug tolerance. Proc Natl Acad Sci U S A (2004) 1.21
Drug-induced epigenetic changes produce drug tolerance. PLoS Biol (2007) 1.18
Conditional protein phosphorylation regulates BK channel activity in rat cerebellar Purkinje neurons. J Physiol (2003) 1.08
Intracellular BK(Ca) (iBK(Ca)) channels. J Physiol (2012) 1.05
Modes of operation of the BKCa channel beta2 subunit. J Gen Physiol (2007) 1.04
Molecular basis for differential modulation of BK channel voltage-dependent gating by auxiliary γ subunits. J Gen Physiol (2015) 1.04
Functional characterization of large conductance calcium-activated K+ channel openers in bladder and vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol (2004) 1.04
Down-regulation of BK channel expression in the pilocarpine model of temporal lobe epilepsy. Brain Res (2008) 0.99
Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain. J Neurochem (2009) 0.95
Tolerance in Drosophila. J Neurogenet (2009) 0.94
A role for BK channels in heart rate regulation in rodents. PLoS One (2010) 0.94
Ca2+- and thromboxane-dependent distribution of MaxiK channels in cultured astrocytes: from microtubules to the plasma membrane. Glia (2009) 0.94
Homeostatic control of neural activity: a Drosophila model for drug tolerance and dependence. Int Rev Neurobiol (2011) 0.89
KCa1.1 channel contributes to cell excitability in unmyelinated but not myelinated rat vagal afferents. Am J Physiol Cell Physiol (2011) 0.89
Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle. PLoS One (2012) 0.88
Electrophysiological properties of BK channels in Xenopus motor nerve terminals. J Physiol (2004) 0.86
Ageing causes cytoplasmic retention of MaxiK channels in rat corporal smooth muscle cells. Int J Impot Res (2007) 0.83
Ion channels and migraine. Headache (2014) 0.82
A DNA element regulates drug tolerance and withdrawal in Drosophila. PLoS One (2013) 0.81
Modulation of glioma BK channels via erbB2. J Neurosci Res (2005) 0.81
The single transmembrane segment determines the modulatory function of the BK channel auxiliary γ subunit. J Gen Physiol (2016) 0.80
Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule. Orphanet J Rare Dis (2014) 0.79
Differential Expression of Large-Conductance Ca-Activated K Channels in the Carotid Body between DBA/2J and A/J Strains of Mice. Front Cell Neurosci (2011) 0.78
Ca(2+)-dependent large conductance K(+) currents in thalamocortical relay neurons of different rat strains. Pflugers Arch (2012) 0.78
Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.78
Targets of polyamine dysregulation in major depression and suicide: Activity-dependent feedback, excitability, and neurotransmission. Neurosci Biobehav Rev (2016) 0.78
Identification and characterization of Ca2+-activated K+ channels in granulosa cells of the human ovary. Reprod Biol Endocrinol (2009) 0.76
Alcohol-Induced Neuroadaptation Is Orchestrated by the Histone Acetyltransferase CBP. Front Mol Neurosci (2017) 0.75
RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J (1995) 1.58
The substituted benzimidazolone NS004 is an opener of the cystic fibrosis chloride channel. J Biol Chem (1994) 1.51
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med (2001) 1.43
Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits. Nat Neurosci (1998) 1.42
Effects of channel modulators on cloned large-conductance calcium-activated potassium channels. Mol Pharmacol (1996) 1.38
1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent. J Med Chem (1989) 1.17
Opening of large-conductance calcium-activated potassium channels by the substituted benzimidazolone NS004. J Neurophysiol (1994) 1.14
Differential expression of the alpha and beta subunits of the large-conductance calcium-activated potassium channel: implication for channel diversity. Brain Res Mol Brain Res (1997) 1.08
Determination of 9-[(2-phosphonylmethoxy)ethyl]adenine in rat urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1991) 0.92
The pharmacology and molecular biology of large-conductance calcium-activated (BK) potassium channels. Adv Pharmacol (1997) 0.92
Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus. Antimicrob Agents Chemother (1990) 0.90
Serine 232 and methionine 272 define the ligand binding pocket in retinoic acid receptor subtypes. J Biol Chem (1998) 0.88
Structural studies of the anti-HIV agent 2',3'-didehydro-2',3'-dideoxythymidine (D4T). Biochem Biophys Res Commun (1991) 0.87
Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids. J Med Chem (1996) 0.84
Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat. J Pharmacol Exp Ther (1999) 0.81
Regulation of transcription-factor activity during growth and differentiation: involvement of the nuclear matrix in concentration and localization of promoter binding proteins. J Cell Biochem (1991) 0.81
Role of retinoic acid receptor gamma in the Rhino mouse and rabbit irritation models of retinoid activity. Skin Pharmacol (1995) 0.79
Synthesis and biological evaluation of an iodinated iberiotoxin analogue, [mono-iodo-Tyr5, Phe36]-iberiotoxin. Int J Pept Protein Res (1996) 0.76
An assessment of the present and future roles of non-ligand gated ion channel modulators as CNS therapeutics. Expert Opin Pharmacother (1999) 0.75
In-vivo activity of retinoid esters in skin is related to in-vitro hydrolysis rate. J Pharm Pharmacol (1995) 0.75
Relationship of APP mRNA transcripts and levels of NGF and low-affinity NGF receptors to behavioral measures of age-related cognitive dysfunction. J Neurosci (1994) 0.75
Prodrugs of 2',3'-didehydro-3'-deoxythymidine (D4T): synthesis, antiviral activity, and rapid pharmacokinetic evaluation. J Pharm Sci (1994) 0.75
The pore complex in nucleocytoplasmic exchange. Cell Biol Int Rep (1988) 0.75